Evaluation of cytogenetic response in CML patients with variant Philadelphia translocation-Reference-Cited by-同舟云学术

Evaluation of cytogenetic response in CML patients with variant Philadelphia translocation

Published:2021-02-25 Issue:1 Volume:18 Page:99-108
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Shetty Dhanlaxmi¹^ORCID,Talker Elizabeth¹,Jain Hemani¹,Talker Judith¹,Patkar Nikhil²³,Subramanian Papagudi²³,Jain Hasmukh³⁴,Bonda Avinash³⁵,Punatar Sachin³⁵,Gokarn Anant³⁵,Bagal Bhausaheb³⁴,Sengar Manju³⁴,Khattry Navin³⁵

Affiliation:

1. Department of Cancer Cytogenetics Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) Tata Memorial Centre Kharghar Navi Mumbai India

2. Hematopathology Laboratory Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) Tata Memorial Centre Kharghar Navi Mumbai India

3. Homi Bhabha National Institute (HBNI) Anushaktinagar Mumbai India

4. Medical Oncology Department Tata Memorial Hospital, Tata Memorial Centre Parel Mumbai India

5. Medical Oncology Department Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) Tata Memorial Centre Kharghar Navi Mumbai India

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13522

Reference21 articles.

1. Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

2. Understanding the molecular basis of imatinib mesylate therapy in chronic myelogenous leukemia and the related mechanisms of resistance;Marcucci G;Clinic Cancer Res.,2003

3. Long‐term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib

4. Variant Philadelphia translocations in chronic myeloid leukemia: A report of five cases

5. Chronic myeloid leukemia with variant chromosomal translocations: results of treatment with Imatinib mesylate;Bhise R;Online J Health Allied Scs.,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does presence of complex translocations involving BCR::ABL1 in chronic myeloid leukemia affect the response rate to tyrosine kinase inhibitors? A systematic review of the literature;Annals of Diagnostic Pathology;2024-08

2. Novel Four-Way Variant Translocation, t(1;9;22;16)(q21;q34;q11.2;q24), in a Patient with Chronic Myeloid Leukemia;Diagnostics;2024-01-30

3. Chronic myeloid leukemia: cytogenetics and molecular biology’s part in the comprehension and management of the pathology and treatment evolution;Egyptian Journal of Medical Human Genetics;2022-03-06